Syncom Formulations (India) LimitedSYNCOMFNSE
Syncom Formulations shareholders approve ₹0.10 final dividend for FY2025-26
As filed · Syncom Formulations (India) Limited has informed the Exchange about General Updates
CapitalImprovingLowmateriality 15 out of 100
What happened
FactMembers approved a final dividend of ₹0.10 per equity share for FY2025-26 at the 38th Annual General Meeting held on 30 September 2026. The dividend applies to 94,00,00,000 equity shares, with eligibility based on the 23 September 2026 record date.
Why it matters
CapitSignal interpretationA dividend moves cash off the balance sheet to shareholders, so it is both a return and a statement about how much cash the business does not need.
Watch next
Fact- Record date
- Payout as a share of profit
Evidence
How CapitSignal classified this
- Reasoning:
- The filing confirms shareholder approval of the declared final dividend and the associated eligibility date. This is a routine shareholder distribution with no additional change to the company’s operations disclosed.
- Matched on:
- the filing's own subject line
- Confidence in the event type:
- 90%